Cargando…
Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most prevalent cancers in human populations worldwide. Huanglian decoction is one of the most important Chinese medicine formulas, with the potential to treat cancer. AIM: To investigate the role and mechanism of Huanglian decoction on HCC cel...
Autores principales: | Li, Min, Shang, Hua, Wang, Tao, Yang, Shui-Qing, Li, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968131/ https://www.ncbi.nlm.nih.gov/pubmed/33776365 http://dx.doi.org/10.3748/wjg.v27.i10.939 |
Ejemplares similares
-
Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
por: Gong, Zhaohui, et al.
Publicado: (2022) -
Transcriptomics Analysis of Candida albicans Treated with Huanglian Jiedu Decoction Using RNA-seq
por: Yang, Qianqian, et al.
Publicado: (2016) -
Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
por: Kunanopparat, Areerat, et al.
Publicado: (2018) -
Huanglian Jiedu Decoction Exerts Antipyretic Effect by Inhibiting MAPK Signaling Pathway
por: Li, Xing, et al.
Publicado: (2021) -
CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020)